202409-33-4(Etoricoxib) Product Description

Etoricoxib Solution, 100ppm Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine Etoricoxib (200 mg) Etoricoxib impurity A Etoricoxib, >=98% 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine ETORICOXIB 5-Chloro-6'-methyl-3-[4-(methylsulfonyl) phenyl]-2,3'-bipyridine 5-chloro-3-(4-Methanesulfonylphenyl)-2-(6-Methylpyridin-3-yl)pyridine Etoricoxib-D4 2,3'-Bipyridine, 5-chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]- Algix Etobrix Etocox Etoxib Etropain Kingcox MK 0663 MK 663 Tauxib Torcoxia Etoricoxib Etoricoxib Etoricoxib API Etoricoxib (MK-663 Etoricoxib Tablets Cis-Anetho 　　 L-791456 Nucoxia Etoricoxib USP/EP/BP EtoricoxibQ: What is Etoricoxib Q: What is the CAS Number of Etoricoxib Q: What is the storage condition of Etoricoxib Q: What are the applications of Etoricoxib Arcoxia Relying on the test yesterday Etoricoxibe Etoricoxib In-House Etoricoxib IP/BP/EP/USP etocoxib 5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine Relying on Kaoxi reference substance Relying on Kaoxi 202409-33-4 C1H1OS Osteoarthritis and Rheumatoid Arthritis Intermediates & Fine Chemicals Pharmaceuticals 202409-33-4